Catalyst Wire Dossier Catalyst Wire Dossier

Vitekta

elvitegravir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Vitekta, covering 2014-11-06 to 2017-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen [NA]

See pricing